gvtcx

NHS Midlands and East Branded Medicines - Tranche A

NHS England Published 2 Oct 2019 Contracts Finder

key details

Value£154,647,000
Statuscomplete
Category (CPV) 33600000
RegionEast Midlands, West Midlands, East of England
Deadline3 Oct 2019
Contract start1 Mar 2020
Contract end28 Feb 2022
Procedureopen
SME suitableYes
OCIDocds-b5fd17-1d021051-40c8-4883-ba04-47625826b7b8

Awards (27)

This procurement was awarded to 27 suppliers. Values shown are per-award; the notice total is £154,647,000.

SupplierValueDateStatus
Accord-UK Ltd shared £418,787,000 15 Jan 2020 active
Allergan UK limited shared £418,787,000 15 Jan 2020 active
Amgen Ltd. shared £418,787,000 15 Jan 2020 active
Biogen Ltd. shared £418,787,000 15 Jan 2020 active
Bristol-Myers Squibb Pharmaceuticals Ltd. shared £418,787,000 15 Jan 2020 active
Celltrion Healthcare United Kingdom Ltd shared £418,787,000 15 Jan 2020 active
Chugai Pharma UK Ltd shared £418,787,000 15 Jan 2020 active
ELI LILLY & COMPANY LIMITED shared £418,787,000 15 Jan 2020 active
Ferring Pharmaceuticals Limited shared £418,787,000 15 Jan 2020 active
Gilead Sciences shared £418,787,000 15 Jan 2020 active
Intrapharm Laboratories Ltd shared £418,787,000 15 Jan 2020 active
Ipsen Limited shared £418,787,000 15 Jan 2020 active
Janssen-Cilag Ltd shared £418,787,000 15 Jan 2020 active
Merck Serono Limited shared £418,787,000 15 Jan 2020 active
Merz Pharma UK Ltd shared £418,787,000 15 Jan 2020 active
MSD shared £418,787,000 15 Jan 2020 active
Napp Pharmaceuticals Ltd shared £418,787,000 15 Jan 2020 active
Novo Nordisk Ltd shared £418,787,000 15 Jan 2020 active
Pfizer Ltd shared £418,787,000 15 Jan 2020 active
Pharmacosmos UK Ltd. shared £418,787,000 15 Jan 2020 active
Roche Products Ltd shared £418,787,000 15 Jan 2020 active
Sandoz Limited shared £418,787,000 15 Jan 2020 active
TAKEDA UK shared £418,787,000 15 Jan 2020 active
TEVA UK Ltd shared £418,787,000 15 Jan 2020 active
UCB PHARMA LTD shared £418,787,000 15 Jan 2020 active
Vifor Pharma UK Limited shared £418,787,000 15 Jan 2020 active
ViiV Healthcare Limited shared £418,787,000 15 Jan 2020 active

description

NHS Framework for the Midlands and East, Branded Medicines - Tranche A plus Cytokine Modulators and other Monoclonal Antibodies.

Offer reference number: CM/PHR/16/5525

CM/PHR/16/5525/01 - NHS Framework for the Midlands and East, Branded Medicines - Tranche A, Period of framework: 1 March 2020 to 28 February 2022 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/16/5525/02 - NHS Framework for the Midlands and East Branded Medicines - Cytokine Modulators and other monoclonal Antibodies, Period of framework: 1 March 2020 to 28 February 2021 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
13 Feb 2020 Award update (awardUpdate) · 07a35b02-80be-48e9-993f-a0537c5f680d-343518

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.